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1. Introduction 
The isolation, purification and characterization f 
coupling factor A from beef heart mitochondria has 
been reported [l-3]. Its subunit composition is 
similar to that of Fr-ATPase [4]. These studies 
revealed that factor A is a different form of mito- 
chondrial Fr-ATPase [5]. It stimulates the activity of 
urea-depleted sub~tochond~al particles in oxidative 
phospho~lation coupled to NADH or succinate 
oxidation, ATP-supported reversed electron flow, and 
Pi-ATP exchange. It differs from Fi-ATPase in that 
it is cold-stable, and the ATPase specific activity is 
latent, although it can be enhanced to match Fr -ATPase 
activity by exposing it to elevated temperatures. 
It has been suggested in the past that the lower 
ATPase activity of factor A may result from the 
presence of mitochondrial ATPase inhibitor [6] in 
amounts ufficient o mask most of the enzyme 
activity [7,8]. Analysis of factor A and Fr-ATPase 
for in~bitor content showed that both had roughly 
the same ~~bitor content (0.4 mol1340 00 g 
ATPase protein) but only Fr had high ATPase activity 
[3]. However, there remained the possibility that the 
inhibitor was bound to a non-specific, non-functional 
site in Fr , but it was located at its proper site in 
factor A leading to masking of the ATPase activity. 
The only way to overcome this criticism is to prepare 
factor A in a form that had zero inhibitor content. 
It was found [9] that membrane bound, as well as 
soluble Fr and Fi-X [IO] preparations form a 
fluorescent complex with the antibiotic inhibitor, 
aurove~in. They reported that a factor A preparation 
did not form such a complex with aurovertin and 
further proposed that it was either dissociated into 
Elsevier/North-Holland Biomedical Press 
subunits or combined with other proteins o as to 
prevent interaction with aurovertin. They also 
recognized that since the preparation had been left 
in prolonged storage before testing, it might have 
lost activity. It was unfortunate that it was not tested 
for catalytic activity before carrying out the 
aurovertin-binding experiments. 
In the light of the above uncertainties, it was con- 
sidered necessary to reexamine factor A and compare 
it with Fr-ATPase with special reference to the 
inhibitor content and aurovertin binding in order to 
settle the long standing controversy on the relationship 
of factor A to Fr-ATPase. 
2. Materials and methods 
Ureadepleted particles were prepared by a modifi- 
cation of the procedure in [ 1,2] as described in table 1. 
Fr-ATPase [I l] and ATPase inhibitor [5] were 
prepared by pub~~ed procedures. Factor A was 
prepared by a modi~cation of the procedure in [ 121. 
Fraction Se containing factor A activity was desalted 
on a 2X20 cm Sephadex G-25 column equilibrated 
with 10 mM phosphate buffer (pH 7.5) containing 
10% glycerol and 0.1 mM DTT. The Sephadex eluate 
was applied to a 2X 12 cm calcium phosphate gel 
column (10 mg Sigma Cl 125 calcium phosphate 
gel.mg-’ S3 on wet wt basis, mixed with 3 parts 
cellulose) and eluted sequentially with 10 mM, 
25 mM and 125 mM phosphate buffers (pH 7.5) 
containing 10% glycerol and 0.1 mM DTT. The 
coupling factor activity was eluted in the 12.5 mM 
buffer. The active fractions were pooled and con- 
centrated to a small volume in a high pressure ultra- 
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Table 1 
Purification of factor A 
Preparation Protein 
(mg) 
Reverse electron flow activity 
Sprc. act. Total 
(pmol NAD red. units 
min-r . mg-‘) 
% 
recovery 
ATPase activity 
Spec. act. 
(pmol NADH oxid. 
. min-’ . mg-‘) 
Units 
Sonic supernatant 
DEAE-cellulose 
fraction 
Ammonium sulfate 
fraction (3555%) 
Calcium phosphate 
gel fraction 
Sepharose 4B 
fraction 
-_ 
673 0.24 161 
31 6.7 206 127 1.2 37.2 
23 6.1 140.3 87 1.5 34.5 
4.4 15.4 67 42 
1.5 15.2 22 14 5.3 7.95 
Beef heart mitochondrial protein (10 g) was processed to obtain factor A. The urea particles for reverse electron flow activity 
assay were made by a modification of the method in [ 11. ETPH was extracted with 0.25 M sucrose-2.0 M urea-l mM ATP at 
0°C for 30 min, washed with 0.25 M sucrose and suspended in the assay medium for storage. The assay medium contained 0.15 M 
Tris-sulfate at pH 7.8,s mM ATP, 20 mM succinate, 10 mM MgCl, and 2 mg/ml bovine serum albumin. The activities of the 
particie and the stimulation provided by factor A were higher than with the system reported in [lf . The Sepharose filtration step 
is necessary to remove significant amount of inactive, contaminate proteins and some ATPase inhibitor. The specific activity in 
the reversed Bectron flow assay, however, shows no increase because of concomitant partial loss during concentration of the 
active fractions from calcium phosphate eluate, In [l?] we reported that some preparations of F,-ATPase contained factor B, as 
shown by ~mmunoelectrophoresis against anti-factor B serum. The gel filtration procedure described here, besides removing 
Pullman inhibitor, also removes contaminating factor B from F,. Preparations of factor A are free of factor 3 contaminatjon 
filtration cell with PM 10 membrane 7 and further 
purified on a 2X 100 cm Sepharose 4B column 
equilibrated with 25 mM Tris-SO4 buffer (pH 7.5) 
10% glycerol, 10 mM phosphate, 0.1 mM DTT and 
0.5 mM EDTA. All the steps were carried out at or 
near 0°C. The results are shown in table 1. This 
preparation was free of propionyl CuA carboxylase 
activity [13] 1 
The coupling activity was assayed by ATPdepen- 
dent NAD reduction by succinate [11 using urea- 
depleted particles. The ATPase activity was assayed 
spectrophotometrically by measuring NADH oxidation 
as in [S] . The enzymatic assays for ATPase inhibitor 
were carried out strictly by the procedure in [6]. 
Propionyl CoA carboxylase activity was measured 
by the procedure in f 131. 
Protein was determined in submitochondrial 
particles by the modified I&ret method f 141 and 
by Lowry’s method [15] in factor A and Fr-ATPase 
preparations. SDS-PAGE (sodium d~decylsulfate 
polyacrylamide gel electrophoresis) was carried out 
as in [ 161 using 12% polyacrylamide gel at pH 7 .O in 
K-phosphate buffer. 
3. Results 
Introduction of the calcium phosphate gel 
chromatography step was primarily for the purpose 
of removing propionyl CoA carboxylase contamina- 
tion [ 12]_ It can be eliminated for routine prepam” 
tions without significant change in specific activity. 
The overall purification of factor A, as measured by 
its ability to stimulate the urea particle in NAD 
reduction, is > 600-fold (table 1). Half-maximal 
stimulation of the urea particle activity was obtained 
at -2-3 @g factor A/mg particle. The purification 
steps were selected to maintain the ATPase activity 
low. ATPase followed the coupling factor activity 
during the purification procedures. 
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3.2. Properties 
The final preparation obtained after gel filtration 
on Sepharose 4B had an ATPase activity of 
5-10 I*mol.min-‘.mg -l. The stimulation of reversed 
electron flow activity was 15-20 ~mol.min-’ .mg-' . 
The ATPase as well as the coupling factor activities 
were cold-stable. The ATPase activity was insensitive 
to oligomycin, DCCD or mercurials. 
3.3. Inhibitor analysis 
For the assay of Pullman inhibitor [6] factor A 
was subjected to heat treatment at 75°C for 4 min as 
in [3 ,181, then allowed to cool to room temperature. 
It was centrifuged to separate the supernatant con- 
taining the inhibitor. Aliquots of the supernatant 
were then incubated with Fr and assayed [6] using 
authentic inhibitor for comparison. The inhibitor 
activity was 1.8 units.mg-’ factor A (table 2). 
Assuming a one-to-one binding of inhibitor to 
factor A and mol. wt 340 000, the expected recovery 
of functional inhibitor according to the data in [6] 
would be -115 units.mg-’ factor A. Our experi- 
mental observations would then indicate an inhibitor 
content of 0.015 mol.mol-r factor A. Parallel analysis 
carried out on two samples of Fr-ATPase prepared 
by the procedure in [ 111 showed an inhibitor content 
of 3.6 and 10.2 units.mg-’ (table 2). For confirma- 
tion, the supernatant fractions obtained from factor A 
and Fr were analyzed on SDS-PAGE. It is evident 
that the heating releases mainly only one polypeptide in 
the supernatant with a molecular weight indistinguish- 
able from the Pullman inhibitor (fig.1). The high 
molecular weight peptide seen in fig.1 B and fig.lC 
was observed only occasionally and seemed to depend 
Table 2 
ATPase inhibitor content of factor A and F ,-ATPase 
ATPase activity Inhibitor content 
(Ctmol.min-’ .mg-‘) (mo1/340 00 g factor) 
Enzymatic SDS-PAGE 
analysis scan 
Factor A 5.0 0.015 0.026 
F, 70.0 0.030 0.063 
F, 70.0 0.085 0.184 
The enzymatic assays for ATPase and ATPase inhibitor 
activities were carried out by the procedure in [6] 
A 
0.20 
0.10 L 
0.20 B 
3 
0.10 
a” L 
0.40 C 
0.30 
0.20 
0.10 
LL 
Fig.1. SDS-PAGE tracings of the supernatant fraction from 
the heat-treated ATPase. The electrophoresis was conducted 
in 12% polyacrylamidegels by the method in [ 161. (A) Super- 
natant fraction obtained from 150 c(g F, after heat treat- 
ment. (B) Same, from 150 pg factor A. (C) Supernatant 
fraction from factor A and 1 pg Pullman inhibitor. 
upon the heating conditions. It appears to be the 
y subunit of Fr . The inhibitor content of the samples 
was computed from the area under the curves, using 
pure inhibitor as standard (table 2). These results 
indicate that the ATPase inhibitor content of factor A 
prepared by the above procedure is < 0.03 mol/mol 
factor A as compared to 0.40 mol obtained in our 
preparation [3], is lower than that of F1 -ATPase, and 
yet it has lower ATPase activity. Evidently, the low 
ATPase activity and the cold stability of factor A 
cannot be attributed to higher inhibitor content. 
3.4. Aurovertin binding 
For the aurovertin binding experiments, a prep- 
aration of factor A was purified on a glycerol gradient 
(1.4-6.9 M) [ 121 instead of Sepharose filtration. 
A constant amount of protein was incubated with 
increasing amounts of aurovertin. The fluorescence 
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of aurovertin was measured using excitation at 
370 nm and emission at 490 nm. The reference had 
similar concentration of aurovertin and enough 
glycogen to parallel the scattering effect due to 
addition of the protein sample in the experimental 
cuvette. Aurovertin binding was determined by the 
fluorescence enhancement with fixed factor A and 
variable aurovertin concentrations. Two experiments 
indicated 1.8 and 2.54 (mean of 2 .17) nmol binding 
sites .mg-’ factor A and Kd 4.34-5.15 X lo-’ M, 
in 50 mM Tris-SO4 buffer (pH 8,O). Based on mol. 
wt 340 000 for factor A, the aurovertin binding 
would amount o 0.74 mol/mol. This value is in the 
range reported for aurovertin binding to Fr [19], 
although avalue of two binding sites has also been 
reported [20]. These results would show that, in 
contrast o [9], factor A does bind aurovertin in 
amounts imilar to that bound by Fr . 
4. Discussion 
Bovine heart Fr containing 6 subunits including 
the ATPase inhibitor and having low ATPase activity 
has been isolated 12 l] . It can be converted to other 
electrophoretica~ydist~ct forms (or ~omorphs) 
by altering the solvent medium. The absence of 
ATPase inhibitor in factor A prepared by the revised 
procedure described here, would distinguish it from 
the 6 subunits preparation, although the ATPase 
activity is latent in both. 
From [ 1,2], we had attributed the low ATPase 
activity of factor A, in contrast o Fr , to a confor- 
mational difference between the two preparations. 
Similar polymorphism has now been seen with E. coli 
Fr which appears to exist in two allomorphs, one 
with low and other with high ATPase activity [22]. 
The change from the low to high activity form is 
brought about by preincubation at higher tempera- 
tures, just as in the case of conversion of factor A 
to Fr [ 1,2]. The most interesting finding, however, 
is that the 4 subunit E. coZi enzyme containing the e 
or inhibitor subunit, as well as the three and two 
subunit forms without the inhibitor, showed the same 
type of transition from the low to the high activity 
form as we had reported earlier for factor A [ 1,2]. 
The results in 12 1] establishing polymorphism in Fr 
preparations and in [22] showing transition of 
16 
E. co& F, from a low ATPase activity form to a high 
activity form are fully consistent with our conclu- 
sions that factor A and Fr probably differ only in 
conformational state. 
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